Insider: Heerma Peter CHIEF COMMERCIAL OFFICER - Travere Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 128,215 | 0 | 128,215 |
| Value | $3,166,910.50 | $0.00 | $3,166,910.50 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 05/05/2025 | DDS | 1,771 | Direct | COM | $21.05 | $37,279.55 | 128,215 |
| 02/12/2025 | DDS | 2,568 | Direct | COM | $23.53 | $60,425.55 | 125,066 |
| 02/11/2025 | DDS | 3,074 | Direct | COM | $25.00 | $76,850.00 | 127,634 |
| 02/03/2025 | DDS | 5,166 | Direct | COM | $20.12 | $103,939.92 | 122,708 |
| 01/22/2025 | DDS | 1,584 | Direct | COM | $18.94 | $30,002.23 | 106,374 |
| 09/09/2024 | DDS | 2,191 | Direct | COM | $11.52 | $25,240.32 | 107,958 |
| 02/01/2024 | DDS | 4,195 | Direct | COM | $8.53 | $35,788.80 | 99,503 |
| 01/23/2024 | DDS | 1,559 | Direct | COM | $9.07 | $14,137.64 | 78,698 |
| 10/03/2023 | DDS | 3,091 | Direct | COM | $8.25 | $25,504.15 | 80,257 |
| 02/01/2023 | DDS | 1,779 | Direct | COM | $21.75 | $38,696.81 | 82,069 |
| 01/24/2023 | DDS | 1,550 | Direct | COM | $21.90 | $33,951.82 | 63,598 |
| 10/04/2022 | DDS | 3,042 | Direct | COM | $25.68 | $78,118.56 | 65,148 |
| 01/31/2022 | DDS | 1,125 | Direct | COM | $27.40 | $30,825.00 | 67,297 |
| 01/24/2022 | DDS | 1,875 | Direct | COM | $24.98 | $46,837.50 | 58,582 |
| 10/04/2021 | DDS | 3,058 | Direct | COM | $24.77 | $75,746.05 | 60,457 |
| 08/17/2021 | DDS | 1,407 | Direct | COM | $17.12 | $24,086.01 | 63,515 |
| 02/08/2021 | DDS | 1,125 | Direct | COM | $31.58 | $35,527.50 | 59,344 |
| 02/05/2021 | DDS | 1,125 | Direct | COM | $31.41 | $35,336.25 | 60,469 |
| 02/03/2021 | DDS | 563 | Direct | COM | $28.91 | $16,276.33 | 57,094 |
| 02/02/2021 | DDS | 563 | Direct | COM | $30.75 | $17,312.25 | 57,657 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research